Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection

Authors Information
Article Notes and Dates
To Cite : Nagao Y, Kawahigashi Y, Sata M. Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection, Hepat Mon. 2014 ;14(12):e23264. doi: 10.5812/hepatmon.23264.
Copyright: Copyright © 2014, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Umemura T, Ichijo T, Yoshizawa K, Tanaka E, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol. 2009; 44 Suppl 19: 102-7[DOI][PubMed]
  • 2. Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, et al. Hepatocellular carcinoma: recent trends in Japan. Gastroenterology. 2004; 127(5 Suppl 1)-26[PubMed]
  • 3. Asahina Y, Tsuchiya K, Tamaki N, Hirayama I, Tanaka T, Sato M, et al. Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection. Hepatology. 2010; 52(2): 518-27[DOI][PubMed]
  • 4. Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, et al. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy. Ann Intern Med. 1999; 131(3): 174-81[PubMed]
  • 5. Yoshida H, Arakawa Y, Sata M, Nishiguchi S, Yano M, Fujiyama S, et al. Interferon therapy prolonged life expectancy among chronic hepatitis C patients. Gastroenterology. 2002; 123(2): 483-91[PubMed]
  • 6. Yamasaki K, Tomohiro M, Nagao Y, Sata M, Shimoda T, Hirase K, et al. Effects and outcomes of interferon treatment in Japanese hepatitis C patients. BMC Gastroenterol. 2012; 12: 139[DOI][PubMed]
  • 7. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S. Periodontal disease and cardiovascular disease. J Periodontol. 1996; 67(10 Suppl): 1123-37[DOI][PubMed]
  • 8. Mealey BL, Oates TW, American Academy of P. Diabetes mellitus and periodontal diseases. J Periodontol. 2006; 77(8): 1289-303[DOI][PubMed]
  • 9. Lopez NJ, Smith PC, Gutierrez J. Higher risk of preterm birth and low birth weight in women with periodontal disease. J Dent Res. 2002; 81(1): 58-63[PubMed]
  • 10. Bascones-Martinez A, Figuero-Ruiz E. Periodontal diseases as bacterial infection. Med Oral Patol Oral Cir Bucal. 2004; 9 Suppl: 101-7[PubMed]
  • 11. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ. Communication among Oral Bacteria. Microbiol Mol Biol Rev. 2002; 66(3): 486-505[DOI]
  • 12. Ishihara K, Nabuchi A, Ito R, Miyachi K, Kuramitsu HK, Okuda K. Correlation between Detection Rates of Periodontopathic Bacterial DNA in Carotid Coronary Stenotic Artery Plaque and in Dental Plaque Samples. J Clin Microbiol. 2004; 42(3): 1313-5[DOI]
  • 13. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998; 25(2): 134-44[DOI]
  • 14. Nakagawa I. Functional Differences among FimA Variants of Porphyromonas gingivalis and Their Effects on Adhesion to and Invasion of Human Epithelial Cells. Infect Immun. 2002; 70(1): 277-85[DOI]
  • 15. Amano A, Nakagawa I, Kataoka K, Morisaki I, Hamada S. Distribution of Porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol. 1999; 37(5): 1426-30[PubMed]
  • 16. Missailidis CG, Umeda JE, Ota-Tsuzuki C, Anzai D, Mayer MP. Distribution of fimA genotypes of Porphyromonas gingivalis in subjects with various periodontal conditions. Oral Microbiol Immunol. 2004; 19(4): 224-9[DOI][PubMed]
  • 17. Yoneda M, Naka S, Nakano K, Wada K, Endo H, Mawatari H, et al. Involvement of a periodontal pathogen, Porphyromonas gingivalis on the pathogenesis of non-alcoholic fatty liver disease. BMC Gastroenterol. 2012; 12: 16[DOI][PubMed]
  • 18. Hashimoto M, Yamanaka K, Shimosato T, Ozawa A, Takigawa T, Hidaka S, et al. Oral condition and health status of elderly 8020 achievers in Aichi Prefecture. Bull Tokyo Dent Coll. 2006; 47(2): 37-43[PubMed]
  • 19. Niwa M, Fukuda M. Clinical study on the control of dental plaque using a photo energy conversion toothbrush equipped with a TiO2 semiconductor. Shigaku. 1989; 77(2): 598-606[PubMed]
  • 20. Kaufman E, Lamster IB. Analysis of saliva for periodontal diagnosis--a review. J Clin Periodontol. 2000; 27(7): 453-65[PubMed]
  • 21. Lee SC, Antony A, Lee N, Leibow J, Yang JQ, Soviero S, et al. Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin Microbiol. 2000; 38(11): 4171-9[PubMed]
  • 22. Sizmann D, Boeck C, Boelter J, Fischer D, Miethke M, Nicolaus S, et al. Fully automated quantification of hepatitis C virus (HCV) RNA in human plasma and human serum by the COBAS AmpliPrep/COBAS TaqMan system. J Clin Virol. 2007; 38(4): 326-33[DOI][PubMed]
  • 23. Dusheiko G, Schmilovitz-Weiss H, Brown D, McOmish F, Yap PL, Sherlock S, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology. 1994; 19(1): 13-8[PubMed]
  • 24. Tadokoro K, Yamaguchi T, Kawamura K, Shimizu H, Egashira T, Minabe M, et al. Rapid quantification of periodontitis-related bacteria using a novel modification of Invader PLUS technologies. Microbiol Res. 2010; 165(1): 43-9[DOI][PubMed]
  • 25. Nagao Y, Sata M. Dental problems delaying the initiation of interferon therapy for HCV-infected patients. Virol J. 2010; 7: 192[DOI][PubMed]
  • 26. Moura-Grec PG, Marsicano JA, Carvalho CA, Sales-Peres SH. Obesity and periodontitis: systematic review and meta-analysis. Cien Saude Colet. 2014; 19(6): 1763-72[PubMed]
  • 27. El-Serag HB, Kanwal F. Obesity and hepatocellular carcinoma: hype and reality. Hepatology. 2014; 60(3): 779-81[DOI][PubMed]
  • 28. Serfaty L, Capeau J. Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data. Liver Int. 2009; 29 Suppl 2: 13-25[DOI][PubMed]
  • 29. Nagao Y, Kawasaki K, Sata M. Insulin resistance and lichen planus in patients with HCV-infectious liver diseases. J Gastroenterol Hepatol. 2008; 23(4): 580-5[DOI][PubMed]
  • 30. Nishimura F, Murayama Y. Periodontal inflammation and insulin resistance--lessons from obesity. J Dent Res. 2001; 80(8): 1690-4[PubMed]
  • 31. Henderson L, Muir M, Mills PR, Spence E, Fox R, McCruden EA, et al. Oral health of patients with hepatitis C virus infection: a pilot study. Oral Dis. 2001; 7(5): 271-5[PubMed]
  • 32. Embery G, Waddington R. Gingival crevicular fluid: biomarkers of periodontal tissue activity. Adv Dent Res. 1994; 8(2): 329-36[PubMed]
  • 33. Ben-Aryeh H, Ur I, Ben-Porath E. The relationship between antigenaemia and excretion of hepatitis B surface antigen in human whole saliva and in gingival crevicular fluid. Arch Oral Biol. 1985; 30(1): 97-9[PubMed]
  • 34. Montebugnoli L, Dolci G. Anti-HCV antibodies are detectable in the gingival crevicular fluid of HCV positive subjects. Minerva Stomatol. 2000; 49(1-2): 1-8[PubMed]
  • 35. Maticic M, Poljak M, Kramar B, Seme K, Brinovec V, Meglic-Volkar J, et al. Detection of hepatitis C virus RNA from gingival crevicular fluid and its relation to virus presence in saliva. J Periodontol. 2001; 72(1): 11-6[DOI][PubMed]
  • 36. Nagao Y, Seki N, Tamatsukuri S, Sata M. Detection of hepatitis C virus in saliva before and after scaling of dental calculus. Kansenshogaku Zasshi. 2000; 74(11): 961-5[PubMed]
  • 37. Persson GR, DeRouen TA, Page RC. Relationship between gingival crevicular fluid levels of aspartate aminotransferase and active tissue destruction in treated chronic periodontitis patients. J Periodontal Res. 1990; 25(2): 81-7[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check